Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Is methylene blue chromoendoscopy useful in detecting short-segment Barrett's?

Two studies in the September issue of Gastrointestinal Endoscopy, which examined the use of methylene blue chromoendoscopy in the diagnosis of Barrett's esophagus, have come to different conclusions.

News image

fiogf49gjkf04

In the first, researchers from Kansas City, Missouri, USA, compared the confirmation of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) by using methylene blue-directed versus random biopsies.

A total of 75 consecutive patients (mean age 64 years) undergoing EGD, in whom columnar-appearing mucosa less than 3 cm in length was visualized, underwent methylene blue (MB) staining.

Stained areas within suspected SSBE segments were targeted for biopsies.

A historical control group consisted of 83 patients (mean age 61 years), with less than 3 cm of columnar-appearing mucosa, in whom biopsy specimens were obtained randomly without MB staining.

Within the MB and control groups, the mean lengths of columnar-appearing mucosa were 1.2 and 1.16 cm, respectively.

Intestinal metaplasia was detected in 61% of the MB group vs 42% of the control group.

Patients in the MB group required significantly fewer biopsies (4.3 vs 5.1).

Confirmation of intestinal metaplasia by length was as follows: less than 1 cm (irregular Z line), MB 17.4% vs control 25%; 1 to less than 2 cm, MB 77% vs control 45%; 2 to less than 3 cm, MB 90% vs control 58%.

Dr Prateek Sharma, of the University of Kansas and Veterans Affairs Medical Center, concluded on behalf of the group, "MB chromoendoscopy significantly increases the detection of intestinal metaplasia. It also requires fewer biopsies in patients with suspected SSBE with greater than 1 cm of columnar-appearing mucosa.

"It does not appear to be beneficial in patients with irregular Z lines (<1 cm)."

Results conflict as to whether MB chromoendoscopy increases detection of intestinal metaplasia.
Gastrointestinal Endoscopy
In the second study, a team from Louisville, Kentucky, USA, enrolled 47 patients with columnar-lined esophagus (CLE) into a randomized crossover trial of MB-directed biopsy vs conventional biopsy. Of these, 19 had long-segment and 28 had short-segment CLE.

Sensitivity and specificity of MB for specialized intestinal metaplasia were found to be 53% and 51%, respectively.

Sensitivity and specificity of MB for dysplasia were 51% and 48%, respectively.

Some 35 patients (15 long-segment CLE; 20 short-segment CLE) completed the crossover trial.

Relative frequencies for specialized intestinal metaplasia were 73% and 71% from MB-directed and conventional biopsy specimens, respectively. The relative frequencies for dysplasia were 20% and 18%, respectively.

In patients with long-segment CLE, dysplasia was diagnosed in 10 patients with MB and 7 patients with conventional biopsy methods.

The number of biopsy specimens per EGD was greater with MB, which may have influenced the diagnosis.

Histologically, the grade of dysplasia was indefinite/low in nearly all of the dysplastic specimens.

Dr John M. Wo and colleagues from the University of Louisville School of Medicine and VA Medical Center, concluded, "Results of MB-directed biopsy were similar to conventional biopsy in detecting specialized intestinal metaplasia and indefinite/low-grade dysplasia.

"MB was not useful in short-segment Barrett's esophagus."

Gastrointest Endosc 2001; 54: 289-93, 294-301
12 September 2001

Go to top of page Email this page Email this page to a colleague

 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
MRI and NAFLD
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us